Treatment of advanced stage Hodgkin lymphoma - it's all about risk-benefit

被引：0
|
作者：
Phipps, Colin [1 ]
Lee, Yuh Shan [1 ]
Hwang, William [1 ]
机构：
[1] Singapore Gen Hosp, Dept Haematol, Singapore 0316, Singapore
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2012年 / 159卷 / 01期
关键词：
Hodgkin lymphoma; radiotherapy; chemotherapy; CHEMOTHERAPY; TRIAL; ABVD;
D O I：
10.1111/j.1365-2141.2012.09234.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：113 / 115
页数：3
相关论文
共 50 条
  • [31] A Risk-Benefit Analysis of Methadone Maintenance Treatment
    James Bell
    Deborah Zador
    Drug Safety, 2000, 22 : 179 - 190
  • [32] A Risk-Benefit Assessment of Octreotide in the Treatment of Acromegaly
    Aart Jan van der Lely
    Wouter W. de Herder
    Steven W. J. Lamberts
    Drug Safety, 1997, 17 : 317 - 324
  • [33] A risk-benefit assessment of mirtazapine in the treatment of depression
    Kasper, S
    PraschakRieder, N
    Tauscher, J
    Wolf, R
    DRUG SAFETY, 1997, 17 (04) : 251 - 264
  • [34] A risk-benefit assessment of sulpiride in the treatment of schizophrenia
    Mauri, MC
    Bravin, S
    Bitetto, A
    Rudelli, R
    Invernizzi, G
    DRUG SAFETY, 1996, 14 (05) : 288 - 298
  • [35] A risk-benefit analysis of methadone maintenance treatment
    Bell, J
    Zador, D
    DRUG SAFETY, 2000, 22 (03) : 179 - 190
  • [36] A risk-benefit assessment of octreotide in the treatment of acromegaly
    vanderLely, AJ
    deHerder, WW
    Lamberts, SWJ
    DRUG SAFETY, 1997, 17 (05) : 317 - 324
  • [37] TREATMENT OF SUICIDAL PATIENTS - A RISK-BENEFIT ANALYSIS
    OVERHOLSER, JC
    BEHAVIORAL SCIENCES & THE LAW, 1995, 13 (01) : 81 - 92
  • [38] A Risk-Benefit Assessment of Mirtazapine in the Treatment of Depression
    Siegfried Kasper
    Nicole Praschak-Rieder
    Johannes Tauscher
    Rainer Wolf
    Drug Safety, 1997, 17 : 251 - 264
  • [39] A RISK-BENEFIT ASSESSMENT OF TEICOPLANIN IN THE TREATMENT OF INFECTIONS
    DELALLA, F
    TRAMARIN, A
    DRUG SAFETY, 1995, 13 (05) : 317 - 328
  • [40] Allogeneic Transplantation for Lymphoma: Risk-Benefit Balance Is in the Eye of the Beholder
    Smith, Mitchell R.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (07) : 905 - 906
12345